Use of PC-SPES, a commercially available supplement for prostate cancer, in a patient with hormone-naive disease

Urology

Volumn 54, Issue 2, 1999, Pages 319-323

  Moyad, Mark A ^a   Pienta, Kenneth J ^a   Montie, James E ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN; HERBACEOUS AGENT; LIPOPROTEIN;

ADULT; ARTICLE; BREAST DISEASE; CASE REPORT; EDEMA; ERECTILE DYSFUNCTION; HAIR LOSS; HERBAL MEDICINE; HORMONAL THERAPY; HUMAN; LIBIDO; MALE; PRIORITY JOURNAL; PROSTATE CANCER;

EID: 0032770547     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-4295(99)00216-2     Document Type: Article

References (31)

1. Hsieh T.C., Chen S.S., Wang X., et al. Regulation of androgen receptor (AR) and prostatic specific antigen (PSA) expression in the androgen-responsive human prostate LNCaP cells by ethanolic extracts of the Chinese herbal preparation PC-SPES. Biochem Mol Biol Int. 42:1997;535-544.
2. Halicka H.D., Ardelt B., Juan G., et al. Apoptosis and cell cycle effects induced by extracts of the Chinese herbal preparation PC-SPES. Int J Oncol. 11:1997;437-448.
3. Délos S., Iehlé C., Martin P.M., et al. Inhibition of the activity of "basic" 5 alpha reductase (type 1) detected in DU 145 cells and expressed in insect cells. J Steroid Biochem Mol Biol. 48:1994;347-352.
4. Iehlé C., Délos S., Guirou O., et al. Human prostatic steroid 5 alpha reductase isoforms - a comparative study of selective inhibitors. J Steroid Biochem Mol Biol. 54:1995;273-279.
5. Zava D.T., Dollbaum C.M., Blen M. Estrogen and progestin bioactivity of foods, herbs, and spices. Proc Soc Exp Biol Med. 217:1998;369-378.
6. Duda R.B., Taback B., Kessel B., et al. pS2 expression induced by American ginseng in MCF-7 breast cancer cells. Ann Surg Oncol. 3:1996;515-520.
7. DiPaola R.S., Zhang H., Lambert G.H., et al. Clinical and biologic activity of an estrogenic herbal combination (PC-SPES) in prostate cancer. N Engl J Med. 339:1998;785-791.
8. Leuprolide versus diethylstilbestrol for metastatic prostate cancer. N Engl J Med. 311:1984;1281-1286.
9. Bishop M.C. Experience with low-dose oestrogen in the treatment of advanced prostate cancer a personal view . Br J Urol. 78:1996;921-928.
10. Seelen M.A., deMeijer P.H., Braun J., et al. Hypertension caused by licorice consumption. Ned Tijdschr Geneeskd. 140:1996;2632-2635.
11. Sigurjonsdottir H.A., Ragnarsson J., Franzson L., et al. Is blood pressure commonly raised by moderate consumption of licorice? J Hum Hypertens. 9:1995;345-348.
12. Beretta-Piccoli C., Salvade G., Crivelli P.L., et al. Body-sodium and blood volume in a patient with licorice-induced hypertension. J Hypertens. 3:1985;19-23.
13. Epstein M.T., Espiner E.A., Donald R.A., et al. Effect of eating liquorice on the renin-angiotensin aldosterone axis in normal subjects. BMJ. 1:1977;488-490.
14. Chang A., Yeap B., Davis T., et al. Double-blind, randomized study of primary hormonal treatment of stage D2 prostate carcinoma flutamide versus diethylstilbestrol . J Clin Oncol. 14:1996;2250-2257.
15. Rossner S., Hedlund P.-O., Joestrand T., et al. Treatment of prostatic cancer effects on serum lipoproteins and the cardiovascular system . J Urol. 133:1985;53-57.
16. Berglund L., Carlstrom K., Stege R., et al. Hormonal regulation of serum lipoprotein (a) levels effects of parenteral administration of estrogen or testosterone in males . J Clin Endocrin Metab. 81:1996;2633-2637.
17. Hiraga T., Shimokawa K., Murase T., et al. Reduction of serum lipoprotein (a) by estrogen in men with prostatic cancer. Endocrin J. 40:1993;507-513.
18. Henriksson P., Angelin B., Berglund L. Hormonal regulation of serum Lp (a) levels. Opposite effects after estrogen treatment and orchidectomy in males with prostatic carcinoma. J Clin Invest. 89:1992;1166-1171.
19. Byar D.P., Corle D.K. Hormone therapy for prostate cancer results of the Veterans Administration Cooperative Urological Research Group Studies . Natl Cancer Inst Monogr. 7:1988;165-170.
20. Carcinoma of the prostate treatment comparisons . J Urol. 98:1967;516-522.
21. Byar D.P. Proceedings the Veterans Administration Cooperative Urological Research Group's studies of cancer of the prostate . Cancer. 32:1973;1126-1130.
22. Citrin D.L., Kies M.S., Wallemark C.-B., et al. A Phase II study of high-dose estrogens (diethylstilbestrol diphosphate) in prostate cancer. Cancer. 56:1985;457-460.
23. Droz J.P., De Smedt E., Kattan J., et al. Phase I trial of high-dose fosfestrol in hormone-refractory adenocarcinoma of the prostate. Prostate. 24:1994;62-66.
24. Aprikian A.G., Fair W.R., Reuter V.E., et al. Experience with neoadjuvant diethystilbestrol and radical prostatectomy in patients with locally advanced prostate cancer. Br J Urol. 74:1994;630-636.
25. Goldenberg S.L., Bruchovsky N., Gleave M.E., et al. Low-dose cyproterone acetate plus mini-dose diethylstilbestrol - a protocol for reversible medical castration. Urology. 47:1996;882-884.
26. Eisenberg D.M., Davis R.B., Ettner S.L., et al. Trends in alternative medicine use in the United States, 1990-1997. JAMA. 280:1998;1569-1575.
27. Agardh C.D., Rasmussen F., Nilsson-ehle P., et al. Influence of treatment with diethylstilbestrol for carcinoma of prostate on platelet aggregation and plasma lipoproteins. Urology. 28:1986;469-471.
28. Emtage L.A., George J., Boughton B.J., et al. Haemostatic changes during hormone manipulation in advanced prostate cancer a comparison of DES 3 mg/day and goserelin 3.6 mg/month . Eur J Cancer. 26:1990;315-319.
29. Hsieh T-Z, Ng C, Chang C-C, et al: Induction of apoptosis and down-regulation of bcl-6 in Mutu I cells treated with ethanolic extracts of the Chinese herbal supplement PC-SPES. Int J Oncol (in press).
30. Craig W.J. Phytochemicals guardians of our health . J Am Dietetic Assoc. 97:1997;S199-S204.
31. Nakata H., Kikuchi Y., Tode T., et al. Inhibitory effects of ginsenoside RH2 on tumor growth in nude mice bearing human ovarian cancer cells. Jpn J Cancer Res. 89:1998;733-740.